Facebook-f Twitter Envelope Instagram

Cancer Patients Alliance
is a 501(c)(3) non-profit.

All DONATIONS are tax-deductible.

Make an impact today!  

DONATE
Previous
Next
You have likely found us either because you have pancreatic cancer, or care about someone who does. Our mission is to promote awareness, increase education, and further pancreatic cancer research aimed at early diagnosis.
Click Here to Contact us
Pancreatic cancer is the 3rd leading cause of cancer-related death in the U.S. It is expected to become the 2nd leading cause of cancer-related death by the year 2020. We need to find the disease earlier!
Donate to Research
Our aim is to present impartial knowledge about pancreatic cancer whereby interested parties can access the range of existing treatment options, to aid patient/doctor partnerships, and thus help medical teams optimize personal treatment strategies.
Click Here to Support the Cause
Pancreatic cancer is the most aggressive of the major cancers, and the least funded. It is nearly always diagnosed too late with 80% of pancreatic cancer patients having a terminal disease.
Click Here to make a tax-deductible Donation
Together we can make a difference! Recently, a seasoned specialist told us that we had the highest social good to donation ratio that they had ever seen in any non-profit. We put all donations to serious use.
Click Here to find ways to Help or Donate
Pancreatic cancer is very aggressive. Fortunately together, so are we. There are many ways in which you can help the fight and make an impact for pancreatic cancer. Find the best way for you by clicking the link below.
Click Here to find ways to Help or Donate
Previous
Next

Author Archives: pancreatica

Abraxane and Gemcitabine for Advanced Pancreatic Cancer

By pancreatica | Published May 14, 2020

One of our favorite pancreatic cancer researchers, Dr. Daniel Von Hoff of TGen in Arizona – together with researchers from the Virginia G Piper Cancer Center – is reporting encouraging clinical trials results for those with advanced pancreatic cancer (ductal adenocarcinoma of the pancreas) treated with a combination of Abraxane plus gemcitabine. Neufachivife . This […]

Posted in Pancreatic Cancer Stories | Comments Off on Abraxane and Gemcitabine for Advanced Pancreatic Cancer

Pancreatic cancer ‘time machine’ exposes plot twist in cell growth and invasion

By pancreatica | Published February 17, 2020

Pancreatic cancer has one of the worst survival rates among cancers. Patients can expect as low as a 9% chance to live for at least five years after being diagnosed. Going back in time to observe how cells with key gene mutations interact and become invasive would help researchers better understand how the cancer starts and identify it sooner. […]

Posted in Pancreatic Cancer Stories | Comments Off on Pancreatic cancer ‘time machine’ exposes plot twist in cell growth and invasion

New treatment shows promise in treating pancreas cancer

By pancreatica | Published January 27, 2020

 Treatment with Lutathera – Study shows promise – A new study published in The Journal of Nuclear Medicine shows long-term effectiveness by PRRT in treating malignant neuroendocrine tumors. The study looked at 44 cases with a median overall survival of 79 months. But with PRRT, 32% of the patients were still alive more than 12 years […]

Posted in Medical Research, Neuroendocrine, Islet-cell and Carcinoid Tumors, Pancreatic Cancer, Pancreatic Cancer Stories | Comments Off on New treatment shows promise in treating pancreas cancer

© 2022 Pancreatica. All rights reserved | Privacy Policy
312 Fountain Avenue, Pacific Grove, California 93950   |   Phone: (831) 658-0600   |   Fax: (831) 658-0518  |  participate@tofightcancer.com

Facebook-f Twitter Envelope Youtube